An Evolutionary Learning Pharmaceutical Laboratory For Cost-saving Eradication Of Malaria In Sub-saharan Through Phytobiotechnology | 13351
Clinical Pharmacology & Biopharmaceutics
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The World Health Organization (WHO) has acknowledged that ?Science still has no Magic bullet for malaria and many do
doubt that such a single solution will ever exist.?In this presentation, focus on the extent of the malaria burden as a global
health challenge, particularly in sub-Saharan Africa (SSA), is discussed. Current and past intervention strategies are reexamined in
the light of myths, sociocultural issues plaguing the sustained use of Long Lasting Insecticide treated bed nets is highlighted.In this
study, emergence of Plasmodium falciparum malarial to Artemisinin based combination therapy and sulfodoxine/pyrimethamine
is presented as well as anti-vector resistance, challenges with vaccines technology, cost barriers militating against effective
eradication of the disease. We conclude this study by presenting the results of the in vitro effect of a peptide of 12kDa isolated
from the aqueous extract of moringa oleifera seeds and beta glucan isolated from sporophore of Ganoderma lucidum both used in
local healing formulae in across Africa, inhibiting the development of Plasmodium berghei in lab mice. The potential application
of Phytopharmaceuticals and nutraceuticals in the treatment of malaria in Sub-Saharan Africa is emphasized. An Evolutionary
Learning Pharmaceutical Laboratory (ELPLab), consisting of a systems approach for cost effective innovations for the possible
eradication of malaria is also proposed.
Kenneth Yongabi Anchang is a Professor of Public Health infectiology with specialty in tropical infectious diseases and public health engineering
at the School of health and medical sciences, Catholic University of Cameroon. Kenneth did his Ph.D. in Chemical Engineering (Biomedical)
at the University of Adelaide, Australia and a Doctor of Science, and Msc in Clinical infectious diseases and clinical/medical microbiology and
naturopathic Medicine in Nigeria and in the USA respectively. He has more than 50 publications in many local and international journals, one book
and three scholarly book chapters spanning through phytopharmaceuticals, infectious diseases, clinical microbiology and bioengineering. Part
of his pioneering work on Phytobiotehnology concept was published in the UNESCO enclopaedia of life Support Systems in 2009. Furthermore,
his research works in this area has been translated into community projects in Africa where Kenneth built the first ecological water filtration unit
in Cameroon using Phytodisinfectants filter system for generating clean water to local school Children and set up a local clinic and laboratory for
screening phytoproducts from plants and macro fungi in Cameroon for the treatment of HIV/AIDS, malaria and some neglected tropical diseases.
He mentors several students at undergraduate and post graduate since 2005 in Nigeria where he was lecturer at ATB University, Bauchi for 5 years
and presently now in Cameroon. He is also an honorary fellow at the University of Wisconsin- Madison in the USA. He is
Director of research at the
Phytobiotechnology research Institute of the Catholic University of Cameroon, Bamenda.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals